Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 3.71
-6.33 %
$ 11.5 M
Market Cap
-0.04
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Bionano Genomics, Inc.
| Revenue | 30.8 M |
| Cost Of Revenue | 30.4 M |
| Gross Profit | 380 K |
| Operating Expenses | 104 M |
| Operating Income | -104 M |
| Other Expenses | 8.03 M |
| Net Income | -112 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 30.8 | 36.1 | 27.8 | 18.0 | 8.5 | 10.1 | 12.0 | 9.5 | 6.8 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 30.4 | 26.6 | 21.9 | 14.1 | 5.7 | 6.8 | 8.7 | 6.0 | 3.6 |
| Gross Profit | 0.4 | 9.6 | 5.9 | 3.9 | 2.8 | 3.4 | 3.3 | 3.5 | 3.2 |
| OPERATING INCOME | |||||||||
| Operating Expenses | 104.4 | 224.8 | 137.6 | 81.0 | 41.3 | 29.2 | 23.7 | 26.1 | 24.4 |
| Selling, General and Administrative Expenses | 51.9 | 95.0 | 88.6 | 58.5 | 31.1 | 20.2 | 14.2 | 14.1 | 13.0 |
| Research and Development Expenses | 24.8 | 54.0 | 49.0 | 22.5 | 10.3 | 9.1 | 9.5 | 12.0 | 11.4 |
| Operating Income | (104.0) | (215.2) | (131.7) | (77.1) | (38.6) | (25.9) | (20.4) | (23.2) | (21.2) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 0.3 | 5.1 | 0.3 | 0.9 | 2.5 | 2.3 | 1.4 | 0.6 | 0.5 |
| Total Other Income | (8.0) | (17.2) | 1.0 | (1.1) | (2.5) | (3.9) | 1.9 | (0.1) | 2.3 |
| Pre-Tax Income | (112.0) | (232.4) | (130.7) | (78.2) | (41.1) | (29.8) | (18.5) | (23.3) | (18.8) |
| NET INCOME | |||||||||
| Tax Provision | 33 K | 62 K | 1.9 | (5.7) | 29.2 K | 21 K | 15.5 K | 18.6 K | 12.9 K |
| Net Income | (112.0) | (232.5) | (132.6) | (72.4) | (41.1) | (29.8) | (18.5) | (23.4) | (18.8) |
| EPS | 60 | 6.81 | 4.58 | 2.62 | 3.95 | 19.9 | 26.1 | 86.5 | 36.1 |